Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback